Skip to Main Content

Information on COVID-19 Vaccination

Smilow Cancer Hospital continues to partner with our colleagues at the Yale New Haven Health System to vaccinate our patients and community. Current guidelines from The National Comprehensive Cancer Network (NCCN) COVID-19 Vaccination Advisory Committee (as of 8/21) recommend that COVID-19 vaccines should be given to all cancer patients, as well as household contacts and caregivers. The U.S. Food and Drug Administration (FDA) amended the emergency use authorizations (EUAs) for both the Pfizer and Moderna COVID-19 Vaccines to allow for the use of an additional dose in certain immunocompromised individuals. This is as a result of medical studies suggesting a reduced antibody response after the usual two-dose vaccine primary series. If you have received a stem cell transplant or CAR T-cell therapy, you should discuss the timing of the third dose of vaccine with your medical team.

At this time, the State of Connecticut has approved access to the vaccine for people 12 and over.
The COVID-19 vaccination is widely recommended for both patients with cancer and for cancer survivors. If you are 12 and over, please login to MyChart and access the COVID-19 scheduling portal or go to www.ynhhs.org/covidvaccine for more information. You can also call the Yale New Haven Health call center at 1-833-ASK-YNHH. If you have had a stem cell transplant or CAR T-Cell therapy, we ask you to contact your oncology provider via MyChart message in advance of your COVID-19 vaccination to discuss the timing of your vaccination.

Please continue to practice extreme precautions to prevent a diagnosis and spread of COVID-19, even after receiving your vaccination; this includes observing social distancing, wearing a mask, and frequently washing your hands.

Your healthcare team remains available to you at any time, and we hope you will reach out with questions or concerns. Additional information is also available by watching the video of our recent Patient and Family Forum or on our Vaccination FAQ webpage.